Terms : Hide Images
| 549326711 | neoplasm | New or abnormal growth | 0 | |
| 549326712 | behavior, anatomical site, morphology type | Neoplasms are classified according to what three criteria? | 1 | |
| 549326713 | malignant | Neoplasm that can invade and destroy adjacent structures and spread to distant sites. | 2 | |
| 549326714 | primary | Type of neoplasm that is contained at the site where it originated. | 3 | |
| 549326715 | secondary | Neoplasm that has spread to another site. | 4 | |
| 549326716 | adjacent structures, local lymph vessels, local blood vessels, body cavities | Secondary neoplasms can spread to (4): | 5 | |
| 549326717 | in situ | Type of neoplasm where tumor cells undergo malignant changes but are still confined to the point of origin without invasion of other tissues. | 6 | |
| 549326718 | benign | Type of neoplasm where growth does not invade adjacent structures or spread to distant sites but may displace or exert pressure on adjacent structures. | 7 | |
| 549326719 | uncertain behavior | Tumors that a pathologist cannot determine as being either benign or malignant. | 8 | |
| 549326720 | unspecified nature | Tumors in which neither the behavior nor the histological type is specified. | 9 | |
| 549338834 | leukemia, melanoma, adenocarcinoma | Morphology types of tumors (3): | 10 | |
| 549338835 | morphology codes | These explain the histology and behavior of a neoplasm. | 11 | |
| 549338836 | histological type, behavior | The first four digits of a morphology code identify the _____. The fifth digit indicates the ______. | 12 | |
| 549338837 | morphology code | M8140/3 is a: | 13 | |
| 549338838 | 0 | Morphology code for benign. | 14 | |
| 549338839 | 1 | Morphology code for uncertain. | 15 | |
| 549338840 | 2 | Morphology code for carcinoma in situ. | 16 | |
| 549338841 | 3 | Morphology code for malignant, primary site. | 17 | |
| 549338842 | 6 | Morphology code for malignant, metastatic site, secondary site | 18 | |
| 549338843 | 9 | Morphology code for malignant, uncertain if primary or secondary. | 19 | |
| 549338844 | higher number | When a diagnosis contains two qualifying adjectives with different morphology codes, you should assign _____. | 20 | |
| 549338845 | M8460/3 | Patient has a papillary (M8050/3) serous (M8460/3) carcinoma or ovary. Which code would you assign? | 21 | |
| 549338846 | v codes | If a patient admission or encounter is solely for the administration of chemotherapy, immunotherapy, or radiation therapy, use _____. | 22 | |
| 549338847 | reason for therapy | When using v codes to describe administration of chemotherapy, etc, an additional code should be used to describe ______. | 23 | |
| 549338848 | malignancy of secondary site | History of cancer can't be reported as the only secondary code. Need an additional code for _____. | 24 | |
| 550277221 | system, organ, site, lymphatic and hematopoietic, skin, lipomas, bone, uterus, ovary | Index classifies neoplasms by (3) ____, _____, _____. Exceptions are neoplasms of ____ system, malignant neoplasms of ____, ____, and common tumors of ___, ____, and ____. | 25 | |
| 550277222 | morphology | When locating neoplasms in index, start by looking for _____. | 26 | |
| 550277223 | functional activity | When coding neoplasms, use additional code to code any _____. | 27 | |
| 550277224 | esophagus, hodgkins disease | Two categories in the malignant section depart from usual principles of classification: | 28 | |
| 550277225 | carcinoid, pancreatic endocrine | Neuroendocrine tumors are classified into _____ and _____ tumors. | 29 | |
| 550277226 | multiple endocrine neoplasia syndrome, endocrine syndrome | When coding neuroendocrine tumors, code first any associated ______. Also, use additional code to identify associated ____. | 30 | |
| 550277227 | primary site | The ____ is defined as the origin of the tumor. | 31 | |
| 550277228 | unknown site or unspecified | If a physician cannot identify the primary site, code _____. | 32 | |
| 550277229 | 195 | When a more specific site cannot be identified, code category ____. | 33 | |
| 550277230 | malignant neoplasm of skin | When a neoplasm is identified as squamous cell or epidermoid carcinoma, code as ______. | 34 | |
| 550277231 | incorrect, skin, ankle | The asterisk following the term "ankle" in the neoplasm table indicates it would be ______ to assign code 195.5 Instead, the malignant column for entry _____...____ should be referenced. | 35 | |
| 550277232 | benign neoplasm of skin | When neoplasm is identified as a papilloma of any type, condition should be classified as _____. | 36 | |
| 550277233 | papilloma, skin, arm | The asterisk following the term "arm" indicates that it would be incorrect to assign code 229.8 if the neoplasm is a _____. The benign column for ___...____ should be referenced. | 37 | |
| 550277234 | 8, other | Neoplasms with overlapping site boundaries are classified to the subcategory ___ or ____. | 38 | |
| 550278062 | malignancy, v10 | When surgical removal of primary site malignancy is followed by adjunct chemo or radiotherapy, the ________ code is assigned as long as chemo/radiotherapy is actively administered. Do not use the _____ code. | 39 | |
| 550278063 | The primary malignant | If a primary malignant neoplasm previously removed by surgery or eradicated by chemo/radiotherapy recurs, the _____ code for that site is assigned. | 40 | |
| 550278064 | primary neoplasm | When cancer is described as "metastatic from" a specific site, it is interpreted as a ______ of that site. | 41 | |
| 550278065 | transplant complication, complication, transplanted organ, malignant neoplasm, transplanted organ, specific malignancy | A malignant neoplasm of a transplanted organ should be coded as a _____. Assign first _____ of _____ then ______ associated with ____. Then use additional code for ______. | 42 | |
| 550701751 | secondary site | A metastatic site is otherwise know as a | 43 | |
| 550701752 | metastatic, direct extension, spread, extension | Other terms that describe a secondary site include (4) | 44 | |
| 550701753 | lymphomas, multiple myeloma, leukemia | What are malignant conditions of lymphatic and hematopoietic tissue (3)? | 45 | |
| 550701754 | type, lymph nodes | Lymphomas are classified according to their ____ and specific _____ involved. | 46 | |
| 550701755 | remission | Multiple myeloma is classified as to whether it is stated to be in ______. | 47 | |
| 550701756 | type, stage | Leukemias are classified according to ____ and ____. | 48 | |
| 550701757 | condition currently exists | Fifth digits in leukemia code identify how _____. | 49 | |
| 550701758 | neoplasm related pain | This code is assigned to pain documented as being related to neoplasm. | 50 | |
| 550701759 | principal diagnosis, underlying neoplasm | Neoplasm related pain may be documented as _____ when reason for admission is pain management. If that is the case, the ______ should be reported as additional diagnosis. | 51 | |
| 550701760 | complication, malignancy | When a patient suffers from complications from a malignancy (dehydration), code the _____ first and then the _____. | 52 | |
| 550701761 | complication, e code, malignancy | When a patient suffers from complications from cancer therapy, code the _____ first and then the _____. Finally, code the _____. | 53 | |
| 550701762 | eradicated, treatment, primary malignancy | History of cancer can be coded when all of the following occur: (1) the primary malignancy has been ____ from its site; (2) no further _____ directed to the site; (3) no evidence of any existing _____. | 54 | |
| 550701763 | secondary site, v10 | For a person who has a history of cancer but then develops a secondary malignancy, the _____ code is assigned first with a _____ code. | 55 |
